Jeffrey Stein Paratek Pharmaceuticals, Inc. (PRTK) insider trading activity

PRTK Quotes by TradingView

Jeffrey Stein is Director of Paratek Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of PRTK, which is worth approximately $0. The most recent transaction as insider was on Sep 21, 2023, when has been sold 68,625 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Jeffrey Stein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 21 2023
SELL
Sale (or disposition) back to the issuer
-
68,625 Reduced 100.0%
0 Common Stock
Feb 21 2023
SELL
Open market or private sale
$13,300 $1.9 p/Share
7,000 Reduced 9.26%
68,625 Common Stock
Feb 08 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 20.92%
75,625 Common Stock
Feb 16 2022
BUY
Grant, award, or other acquisition
-
20,000 Added 26.45%
55,625 Common Stock
Feb 18 2021
BUY
Grant, award, or other acquisition
-
9,000 Added 20.17%
35,625 Common Stock

Also insider at

IDYA
IDEAYA Biosciences, Inc. Healthcare
CDTX
Cidara Therapeutics, Inc. Healthcare
President & CEO
JS

Jeffrey Stein

Director
San Diego, CA

Track Institutional and Insider Activities on PRTK

Follow Paratek Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRTK shares.

Notify only if

Insider Trading

Get notified when an Paratek Pharmaceuticals, Inc. insider buys or sells PRTK shares.

Notify only if

News

Receive news related to Paratek Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PRTK